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Abstract 
Purpose: To investigate the possible hepatoprotective potential of Parthenium hysterophorus crude 
extract (Ph.Cr) against carbon tetrachloride (CCL4)- and paracetamol-induced hepatotoxicity in rabbits. 
Methods: Twenty rabbits were divided into five groups of four rabbits each. Group 1 served as normal 
control and received normal saline (5 mL/kg). Group 2 received normal saline followed by CCL4 (0.75 
mL/kg p.o dose) after 1 h. Groups 3 and 4 received Ph.Cr at doses of 15 and 30 mg/kg po, respectively, 
for 7 days followed by one dose of CCL4, 2 h after the last extract dose (0.75 mL/kg, sc). Group 5 
received silymarin as reference standard at a dose of 100 mg/kg orally for 7 days followed by one dose 
of CCL4 (0.75 mL/kg, sc), 2 h after the last drug dose. The effect of the extract on potassium (K+)-
induced contractions in isolated rabbit jejenum was also evaluated. At the end of the study, the animals 
were sacrificed and their liver architecture examined microscopically. 
Results: Pre-treatment of rabbits with Ph.Cr reduced ALT, ALP and TB levels (p < 0.05, p < 0.01, p < 
0.001) dose dependently. Hepatoprotective data indicate that Ph.Cr markedly reduced CCL4- and 
paracetamol-induced toxicity by preserving the histological architecture of the liver tissue at near 
normal. In isolated rabbit jejunum tissue, Ph.Cr relaxed high K+ (80 Mm)-induced contractions in a 
concentration-dependent (0.03 - 10 mg/mL) manner like that caused by silymarin. 
Conclusion: In the light of the results obtained, Parthenium hysterophorous possesses 
hepatoprotective activity against CCL4- and paracetamol-induced hepatic damage, possibly mediated 
via its antioxidant and Ca++ antagonist mechanisms. 
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The liver is a vital organ of human body 
responsible for biotransformation of many 
endogenous and exogenous substances. It plays 
a significant role in removal of many drugs and 
toxins from the body. Changes in hepatocytes 
biochemistry and generation of reactive oxygen 
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species results in disturbances of these functions 
[1]. Numerous medicinal plants are used for the 
treatment of liver disorders. Because of more 
effectiveness, less consequences of side effects 
and low cost, natural remedies are now 
considered to be safe and effective alternative for 
treating hepatotoxicities. 
 
Parthenium hysterophorus is an annual herb 
belongs to the family Asteraceae and commonly 
known as Carrot weed, Congress weed, Star 
weed and Chatak Chandani. It is native to North 
and South America, but usually it is found in 
many other parts of the world and is a constant 
flourishing component of the flora [2]. Parthenium 
hysterophorus exhibits analgesic activity in 
neuralgia, antipyretic tonic and as febrifuge. Its 
root decoctions have shown significant activity in 
hepatic amoebiasis. The plant has been reported 
to exhibit promising antimicrobial, antioxidant, 
free radical scavenging and lipoprotective 
activities [3]. In this study, hepatoprotective 
action of Parthenium hysterophorous was 
observed against carbon tetrachloride (CCl4) and 
paracetamol-induced hepatotoxicity in rabbits.
 .  
EXPERIMENTAL 
 
Plant material and extraction 
 
Whole plant of Parthenium hysterophorus was 
collected in the month of August 2015, from 
various areas of Islamabad and Rawalpindi, 
Pakistan. The plant was authenticated by Dr 
Mushtaq Ahmad, a taxonomist at Department of 
Plant Sciences, Quaid-a-Azam University, 
Islamabad, and a voucher specimen (no. 
175200) was submitted to the same 
Department’s Herbarium. The plant material (5.2 
kg) was dried under shade and crushed into 
coarse powder. The crushed material was 
allowed to soak for 7 days in 3 L of 70 % 
aqueous-ethanol at room temperature, stirring 
continuously at regular intervals. The extract was 
filtered via a Whatmann filter paper no. 1 and 
concentrated in a rotary evaporator. The 
obtained thick semi-solid paste of Parthenium 
hysterophorus crude extract (Ph.Cr) was 
dissolved in 5 % dimethyl sulphoxide (DMSO). 
The concentrated dried crude extracts were 




Chemicals used in this study with sources are 
specified: CCL4, ethanol, potassium chloride 
(KCL), verapamil (Sigma Chemicals Company, 
USA), assay kits for alanine transaminase (ALT), 
alkaline phosphatase (ALP) and total bilirubin 
(TB) (Merck, Germany), silymarin (Abbott 
Laboratories), paracetamol (olive laboratories, 
Islamabad), DMSO (Labscanasia Company, 
Thailand), methyl cellulose (Colorcon USA), and 
olive oil (Marhaba Laboratories, Lahore) 1 % of 
methyl cellulose (50 mg/mL) and (20 % v/v) of  
olive oil were employed for the suspension of 
paracetamol and CCl4 respectively. Chemicals 





Healthy rabbits (local breed) of either sex, 
weighing between 1.5 - 2 kg were obtained from 
the local market. The animals were housed 
under hygienic conditions at 23 - 25 °C in the 
Animal House of Riphah Institute of 
Pharmaceutical Sciences, supplied with standard 
diet and water ad libitum. All the experiments on 
animals were performed with a prior permission 
from Riphah Institute of Pharmaceutical Sciences 
Ethical committee (ref no. REC/RIPS/2015/004) 
and fulfilled guidelines of Institute of Laboratory 
Animal Resources, Commission on Life Sciences 
University, National Research Council [4]. 
 
Preliminary phytochemical screening 
 
Preliminary phytochemical analysis was carried 
for detection of different classes like alkaloids, 
tannins, saponins, proteins, steroids and 
flavonoids according to standard procedures with 
modifications [5]. Dragendorff’s and Mayer’s 
reagent detected alkaloids. Yellow color was 
detected with sodium hydroxide which indicates 
the positive test for flavonoids. Cream yellow 
color was appeared with lead acetate which 
specified the presence of tannins. Amino acids 
were detected using ninhydrin reagent, blue color 
indicated presence of amino acids steroids were 
considered positive, if plant material treated with 
chloroform and sulfuric acid subsequently 
produced red coloration. Bubbles appearance 
upon vigorous shaking of diluted samples 
indicated presence of saponins. 
 
Induction of hepatic injury 
 
Administration of CCL4 subcutaneously at a dose 
of 0.75 mL/kg suspended in olive oil 1:1 induced 
hepatic injury [6] in the first model, while 2 g/kg 
dose of paracetamol was used to induce 
hepatotoxicity in the second model [7]. The 
saline group (normal control) received normal 




The models of CCL4 and paracetamol-induced 
hepatic injury were used to evaluate 
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hepatoprotective activity. In first model, five 
groups of rabbits consisted of four animals each. 
Group 1 served as normal control and received 
normal saline (5 mL/kg). Group 2 received 
normal saline followed by CCL4 (0.75 mL/kg p.o 
dose) after 1 h. Groups 3 and 4 received Ph.Cr 
at doses of 15 and 30 mg/kg po, respectively, for 
7 days followed by one dose of CCL4, 2 h after 
the last extract dose (0.75 mL/kg, sc). Group 5 
received silymarin as reference, standard at dose 
of 100 mg/kg orally for 7 days followed by one 
dose of CCL4 (0.75 mL/kg s.c), 2 h after the last 
drug dose [6]. In paracetamol induced 
hepatotoxicity, five groups of rabbits were made 
each containing four animals. All these groups 
were treated similar to CCL4 induced 
hepatotoxicity for a period of 7 days. After 
respective drug treatments administration on the 
7th day, all rabbits of group 2, 3, 4 and 5 were 
challenged with paracetamol at dose of 2g/kg 
orally [7]. 
 
Assessment of hepatic injury 
 
Hepatotoxicity was assessed by measuring 
alanine aminotransferase (ALT), alkaline 
phosphatase (ALP) and total bilirubin (TB) levels 
in serum along with changes in histopathology of 
liver. From all groups blood samples were 
collected, 24 and 12 h after CCL4 and 
paracetamol administration respectively. The 
blood (3 mL) was drawn from jugular vein of 
rabbits using sterile disposable syringe and were 
allowed to clot in sterile gel tubes at room 
temperature for 45 minutes. Serum was 
separated through centrifugation at 3000 rpm for 
30 minutes and was then biochemically analyzed 
for the evaluation of ALT, ALP and TB 
spectrophotometrically, using Merck diagnostic 
kits [6]. 
 
Isolation of rabbit jejunum 
 
Rabbits were sacrificed after fasting for 24 h. 
Intestinal segments of approximately 2 cm in 
length were suspended in tissue bath containing 
10 mL of Tyrode’s solution maintained at 37 C, 
bubbled with 95 % oxygen in carbon dioxide [8]. 
Tyrode’s solution composition in mM was KCl 
2.7, NaCl 136.9, NaHCO3 11.9, MgCl2.6H2O 0.5, 
CaCl2 1.8, NaH2PO4.2H2O 0.32 and glucose 
5.05. Intestinal responses were recorded via 
force transducer coupled to a Transbridge and 
Power Lab 4/25 data acquisition system (AD 
Instrument, Sydney Australia). 
 
Determination of Ca++antagonist effect 
 
High K+ (80mM) was employed for evaluation of 
calcium channel blocking (CCB) action, in order 
to depolarize the isolated jejunum preparations 
[9]. The control response percentage arbitrated 
by K+ was estimated by intestinal preparations 




Data are expressed as mean  standard error of 
mean (SEM, n= number of experiment). 
Statistical comparison between various groups 
was analyzed using one-way analysis of variance 
(ANOVA) followed by Tukey post-hoc test with 







Ph.Cr showed positive tests for alkaloids, 
flavonoids, saponins, tannins, steroids, amino 
acids and carbohydrates. 
 
Effect of Ph.Cr on CCL4-induced hepatic 
damage 
 
Ph.Cr dose-dependently (15-30 mg/kg) 
prevented CCL4-induced raise in levels of ALT, 
ALP and TB (Table 1). In saline treated group, 
ALT, ALP and TB values were 52.50 ± 2.10 IU/L, 
156.50 ± 5.62 IU/L and 0.70 ± 0.04 mg/dL 
respectively. CCL4 (0.75mL/kg) treatment raised 
levels of ALT, ALP and TB to 257.80 ± 6.82 IU/L, 
305.50 ± 20.90 IU/Land 1.40 ± 0.09 mg/dL 
respectively (p < 0.001vs. saline group). In Ph.Cr 
(15mg/kg) pretreated group, ALT, ALP and TB 
levels reduced to 167.30 ± 4.32 IU/L, 194.80 ± 
4.11 IU/L (p < 0.001 vs. CCL4 group) and 1.09  ± 
0.04 mg/dL (p < 0.05 vs. CCL4 group) 
respectively. In Ph.Cr (30 mg/kg) pretreated 
group, ALT, ALP and TB levels decreased to 
86.50 ± 3.79 IU/L, 169.00 ± 5.7 IU/L and 0.85 ± 
0.02 mg/dL respectively (p < 0.001 vs. CCL4 
group). In silymarin (100 mg/kg) pretreated 
group, ALT, ALP and TB values were to 80.00 ± 
2.94 IU/L, 164.30 ± 4.90 IU/L and 0.76 ± 0.04 
mg/dL respectively (p < 0.001 vs. CCL4 group) as 
shown in Table 1. Histopathologies were further 
performed, which collaborated the results. In 
saline group, normal hepatic cells are 
characterized by having well-defined cell linings, 
prominent nucleus and central vein (Figure 1A). 
Liver histopathology of CCL4 treated group 
showed hepatocyte necrosis, vacuolization of 
cytoplasm, hepatocytes distoration and fatty 
degeneration (Figure 1B). These 
histopathological changes were partially 
prevented by Ph.Cr pretreatment at dose of 15 
mg/kg, showing mild portal inflammatory infiltrate 
with bile canalicular dilatation (Figure IC). Ph.Cr 
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pretreatment at 30 mg/kg showed normal 
histopathology with intra-hepatic cholestasis only 
with absence of any congestion and focal 
necrosis (Figure ID). Silymarin (100 mg/kg) 
pretreated group, showed normal hepatocytes 
with nucleus and central vein surrounded by 
reticular fibers (Figure IE). 
 
Effect of Ph.Cr on paracetamol-induced 
hepatic damage 
 
Ph.Cr exhibited significant effect in protecting 
liver against paracetamol-induced hepatotoxocity 
(Table 2). In saline treated group, ALT, ALP and 
TB values were 66.50 ± 10.81 IU/L, 169.00 ± 
11.23 IU/L and 0.66 ± 0.61 mg/dL respectively. 
Paracetamol (2 g/kg) treatment raised levels of 
ALP, ALP and TB to 289.50 ± 8.85 IU/L, 306 ± 
8.60 IU/L and 1.44 ± 0.07 mg/dL respectively (p 
< 0.001vs. saline group). In Ph.Cr (15 mg/kg) 
pretreated group, ALT, ALP and TB levels were 
reduced to 186.00 ± 7.15 IU/L, 239.90 ± 6.66 
IU/L (p < 0.001 vs. paracetamol group) and 1.11 
± 0.68 mg/dL(p < 0.01 vs. paracetamol group) 
respectively. In Ph.Cr (30 mg/kg) pretreated 
group, ALT, ALP and TB levels decreased to 
109.30 ± 5.70 IU/L, 209.50 ± 4.97 IU/L and 0.81 
± 0.40 mg/dL respectively (p < 0.001 vs. 
paracetamol group). In silymarin (100 mg/kg) 
pretreated group ALT, ALP and TB values were 
81.50 ± 4.05 IU/L, 181.30 ± 4.90 IU/L and 0.71 ± 
0.02 mg/dL respectively (p < 0.001 vs. 
paracetamol group) as shown in Table 2. In the 
saline group, normal hepatic cells are 
characterized by having well-defined cell linings, 
prominent nucleus and central vein. (Figure 1 A). 
In paracetamol treated group, histopathology of 
liver tissue showed necrosis, ballooning of 
cytoplasm, hepatocytes distoration and 
hematoma of central vein (Figure 2B). In case of 
Ph.Cr (15 mg/kg) pretreatment, liver tissue 
showed centrilobular canaliculi dilatation, with 
mild intracellular cholestasis (Figure 2C). In case 
of Ph.Cr (30 mg/kg) pretreatment, liver tissue 
showed mild intracellular cholestasis only with 
absence of any necrosis and fatty degeneration 
(Figure 2D). Silymarin (100 mg/kg) pretreated 
group had a normal histopathology with well-
defined cell linings, prominent nucleus and 
central vein surrounded by reticular fibers 
showing lack of any necrosis and fatty 
degeneration (Figure 2E). 
 
Effect of Ph.Cr on K+ (80 mM)-induced 
contractions 
 
In isolated rabbit jejunum preparations, Ph.Cr 
and verapamil caused inhibition of K+ (80 mM)-
induced contractions with respective EC50 values 
of 0.50 mg/mL (0.41-0.60 mg/mL, 95% CI, n = 3) 
and 0.18 µM (0.13 - 0.23 µM, n = 3), as 




Figure 1: Representative photomicrographs (40× 
magnification, hematoxylin and eosin staining), 
showing protective effect of Parthenium hysterophorus 
crude extract (Ph.Cr) and silymarin against carbon 
tetrachloride (CCL4)-induced histopathological 
changes in rabbit liver. A: saline (5 mL/kg) treated 
group: tissue showing normal central vein, plates of 
hepatocytes, composed of portal tract surrounded by 
hepatocytes. B: CCL4 (0.75 mL/kg) intoxicated group: 
showing areas of hepatocyte necrosis, distortion of 
hepatocytes and hematoma of central vein as well as 
infiltration of the lymphocytes and kuffer cells around 
central vein. C: Ph.Cr (15 mg/kg) pretreated liver 
tissue, showing mild portal inflammatory infiltrates, bile 
canalicular dilatation with absence of hepatocyte 
necrosis. D: Ph.Cr (30 mg/kg) pretreated liver tissue, 
showing intra hepatic cholestasis only having normal 
central vein, plates of hepatocytes with absence of 
hepatocyte necrosis. E: silymarin (100 mg/kg) 
pretreatment shows normal histopathology with well-
defined central vein, plates of hepatocytes with 
absence of any necrosis 
 
Table 1: Inhibitory effect of crude extract (Ph.Cr) Parthenium hysterophorus and silymarin against carbon 
tetrachloride (CCL4)-mediated increase in alanine transaminase ALT, ALP and total bilirubin TB levels of rabbits 
 
Treatment ALT (IU/L) ALP (IU/L) TB (mg/dL) 
Saline (5 mL/kg) 52.50 ± 2.10 156.50 ± 5.62 0.70 ± 0.04 
CCL4 (0.75 mL/kg) 257.80 ± 6.82# 305.50 ± 20.90# 1.40 ± 0.09# 
Ph.Cr (15 mg/kg) + CCL4 (0.75 mL/kg) 167.3 ± 4.32*** 194.8 ± 4.11*** 1.093 ± 0.047* 
Ph.Cr(30 mg/kg) + CCL4 (0.75 mL/kg) 86.50 ± 3.79*** 169.0 ± 5.70*** 0.85 ± 0.02*** 
Silymarin (100 mg/kg) + CCL4 (0.75mL/kg) 80.00 ± 2.94*** 164.30 ± 4.90*** 0.76 ± 0.04*** 
Values are mean ± SEM (n = 4). #p < 0.001 vs. saline group, *p < 0.05, ***p < 0.001 vs. CCL4 treated group, one 
way ANOVA with Tukey post-hoc test. IU=International Unit 
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Table 2: Inhibitory effect of Parthenium hysterophorus crude extract (Ph.Cr) and silymarin against paracetamol-
mediated increase in alanine transaminase (ALT), alkaline phosphatase (ALP) and total bilirubin (TB) levels of 
rabbits. 
 
Treatment ALT (IU/L) ALP (IU/L) TB (mg/dL) 
Saline (5 mL/kg) 66.50 ± 10.81 169.00 ± 11.23 0.66 ± 0.61 
Paracetamol (2 g/kg) 289.50 ± 8.85# 306.00 ± 8.60# 1.44 ± 0.07# 
Ph.Cr (15 mg/kg) + paracetamol (2 g/kg) 186.00 ± 7.15*** 239.90 ± 6.66*** 1.11 ± 0.68** 
Ph.Cr  (30 mg/kg) + paracetamol (2 g/kg) 109.30 ± 5.70*** 209.50 ± 4.97*** 0.81 ± 0.40*** 
Silymarin (100 mg/kg) + paracetamol (2 g/kg) 81.50 ± 4.05*** 181.30 ± 4.90*** 0.71 ± 0.02*** 
Values are mean ± SEM (n=4). #p < 0.001 vs. saline treated group, **p < 0.01, ***p < 0.001 vs. paracetamol 




Figure 2: Representative photomicrographs (40× 
magnification, hematoxylin and eosin staining), 
showing protective effect of Parthenium hysterophorus 
crude extract (Ph.Cr) and silymarin against 
paracetamol-induced histopathological changes in 
rabbit liver. A: saline (5 mL/kg) treated group: showing 
normal central vein, plates of hepatocytes, composed 
of portal tract surrounded by hepatocytes. B: 
paracetamol (2 g/kg) intoxicated group: shows areas 
of hepatocytes necrosis, distoration of hepatocytes 
and hematoma of central vein as well as infiltration of 
the lymphocytes and kuffer cells around central vein. 
C: Ph.Cr (15 mg/kg) pretreated liver tissue, showing 
centrilobar, canalicular dilatation with mild intracellular 
cholestasis. D: Ph.Cr (30 mg/kg) pretreated liver 
tissue, showing well defined central vein, plates of 
hepatocytes and absence of necrosis with mild 
intracellular cholestasis. E: silymarin (100 mg/kg) 
pretreatment shows nearly normal histopathology with 
absence of any necrosis and have normal central vein 





Figure 3: Concentration-response curves showing 
inhibitory effect of Parthenium hysterophorus crude 
extract (Ph.Cr) and verapamil on K+ (80 mM) induced 
contractions in isolated rabbit jejunum preparations. 




Paracetamol and CCL4 are the most commonly 
used hepatotoxicants in experimental models to 
investigate hepatoprotective effects [10]. 
Biochemical markers in blood along with 
histopathological assessment of liver sections 
shows the degree and type of liver damage, 
while restoration of serum enzyme levels towards 
its respective normal values by the test drug 
treatment defines its hepatoprotective potential. 
Carbon tetrachloride and paracetamol intoxicated 
groups showed increased level of biochemical 
markers: ALT, ALP and TB along with damaged 
liver architecture. Halogenated free radicals are 
formed by CYP2E1 as a result of CCl4 
metabolism [11]. While paracetamol is 
metabolized to N-acetyl-p-benzoquinone 
imine (NAPQI), a toxic reactive intermediate, 
through different cytochrome P-450 (CYPs) 
isozymes i.e., CYP1A2 [12], CYP2D6 and 
CYP3A4 [13]. Hepatotoxic doses of paracetamol 
deplete normal levels of glutathione results in 
widespread production of reactive free radicals, 
causing severe damage to the liver [14]. The 
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most remarkable pathological characteristics of 
CCL4-induced hepatotoxicity are cirrhosis, fatty 
liver and necrosis [15]. This hepatotoxicity 
mediated by reactive species can be managed 
effectively by agents which possesses anti-
oxidant, anti-lipid peroxidation and free radical 
scavenging activities [16].   
 
In this study, an attempt was made to investigate 
hepatoprotective activity of Parthenium 
hysterophorus and to elucidate the underlying 
mechanisms involved in this protection. Ph.Cr 
significantly attenuated CCL4 and paracetamol 
hepatotoxic effects in a dose dependent fashion. 
These effects were comparable to silymarin, a 
reference hepatoprotective agent [17].  
 
This ability of the plant extract shows that 
restoration of these biochemical markers may be 
due to its potential cytochrome P-450 inhibitory 
effects. Moreover, the potential of the plant 
extract to reduce level of enzymes could be 
attributed to its ability of prevent peroxidative 
degradation of endoplasmic reticulum membrane 
lipids. This phenomenon could be achieved via 
the antioxidant activity of Ph.Cr as earlier 
reported [3]. Apart from these, the presently 
evaluated hepatoprotective activity of Ph.Cr 
could be linked to other possible mechanisms. 
Studies suggest that xenobiotics activate ligand-
activated transcription factors like peroxisome 
proliferators activated receptor-α (PPAR-α) which 
are highly expressed in hepatocytes and play a 
crucial role in fatty acid oxidation [18]. 
 
Interestingly it has been reported that flavonoids 
and saponins which are present in Ph.Cr also 
activates PPAR-α system contributing in 
prevention of CCL4 and paracetamol-induced 
hepatotoxicity [19,20]. This mechanism of 
activating PPAR-α system could be attributed to 
role of flavonoids and saponins present in 
Parthenium hysterophorus, playing role in 
prevention of CCL4 and paracetamol-induced 
hepatotoxicity. Alkaloids, flavonoids and 
saponins are phytochemical constituents present 
in Ph.Cr having free radical scavenging, 
antioxidant and lipid peroxidation inhibition 
abilities.   
 
In isolated tissue experiments, Ph.Cr caused 
relaxation of high K+-induced contractions, 
likewise verapamil, a standard Ca++ antagonist 
[21], suggesting CCB effect of Parthenium 
hysterophorus. At elevated concentration (> 30 
mM), K+ causes contraction of smooth muscles 
by opening L-type Ca++ channels, causing a 
contractile effect through influx of extracellular 
Ca++. Any substance triggering high K+-induced 
contraction inhibition is said to be an inhibitor of 
Ca++ influx [22]. Excessive calcium ions in 
hepatocytes cytosol causes changes in cell 
plasma membrane integrity along with its 
organelles, leads to deterioration of DNA and 
activates phospholipases, proteases and 
endonucleases, which causes degradation of 
essential proteins [23]. There are special binding 
sites for calcium channel blockers (CCBs) in the 
inner mitochondrial membrane, which in turn 
inhibit calcium influx, resulting in reduce 
production of macrophage related cytokines. 
 
The hepatoprotective action of Parthenium 
hysterophorus may be attributed to the existence 
of flavonoids, tannins and saponins, as such 
chemicals of such classes have been reported to 
demonstrate hepatoprotective, antioxidant and 




The findings of this study indicate that 
Parthenium hystreophorus exhibits 
hepatoprotective activity by attenuating elevated 
levels of biochemical markers, possibly mediated 
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